The mission of the RegenMed Development Organization (ReMDO) is to accelerate the discovery and translation of regenerative medicine therapies. ReMDO is a 501(c)3 non-profit organization that manages a clinical translation initiative that includes thought leaders, representatives from leading US research centers, government representatives, and companies of all sizes. ReMDO conducts research to de-risk technologies and speed up the translation of regenerative medicine to clinical practice and to the global market.
About Us
ReMDO conducts research to de-risk technologies and speed up the translation of regenerative medicine to clinical practice and to the global market.
Read MoreWhy Us
With projects in advanced biomanufacturing and business incubator services, ReMDO provides a unique opportunity for academia and enterprise to join forces.
Read MoreJoin Us
ReMDO manages multiple societies and consortia of more than 60 industry and academic members that are focused on making this progress a reality.
Read MoreResearch
ReMDO conducts regenerative medicine research with an ultimate goal to de-risk and accelerate the transition of regenerative medicine technologies to the global market and speed up the translation to clinical practice to help make patients lives better.
Know More
News & Events
Virtual Workshop: User Roadmap for Body-on-a-Chip Technology
Wed, June 23, 2021
10:00 AM – 4:00 PM EDT
Virtual
2021 Regenerative Medicine Essentials Course & World Stem Cell Summit
June 14-18, 2021
Virtual